180 related articles for article (PubMed ID: 1426104)
1. Effects in vivo of recombinant human inhibin on myelopoiesis in mice.
Hangoc G; Carow CE; Schwall R; Mason AJ; Broxmeyer HE
Exp Hematol; 1992 Nov; 20(10):1243-6. PubMed ID: 1426104
[TBL] [Abstract][Full Text] [Related]
2. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
5. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
6. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
7. Effects in vivo of purified recombinant human activin and erythropoietin in mice.
Broxmeyer HE; Hangoc G; Zucali JR; Mason A; Schwall R; Carow C; Cooper S
Int J Hematol; 1991 Dec; 54(6):447-54. PubMed ID: 1793828
[TBL] [Abstract][Full Text] [Related]
8. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
9. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
[TBL] [Abstract][Full Text] [Related]
11. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
12. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.
Broxmeyer HE; Lu L; Cooper S; Schwall RH; Mason AJ; Nikolics K
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9052-6. PubMed ID: 3194407
[TBL] [Abstract][Full Text] [Related]
13. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
14. Regulation of myelopoiesis by murine fibroblastic and adipogenic cell lines.
Hangoc G; Daub R; Maze RG; Falkenburg JH; Broxmeyer HE; Harrington MA
Exp Hematol; 1993 Apr; 21(4):502-7. PubMed ID: 8462659
[TBL] [Abstract][Full Text] [Related]
15. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
Cooper S; Mantel C; Broxmeyer HE
Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
17. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha.
Maze R; Sherry B; Kwon BS; Cerami A; Broxmeyer HE
J Immunol; 1992 Aug; 149(3):1004-9. PubMed ID: 1634758
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
19. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
20. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
